Holmgren J, Svennerholm A M, Gothefors L, Jertborn M, Stoll B
Department of Medical Microbiology, University of Göteborg, Sweden.
Infect Immun. 1988 Jan;56(1):230-3. doi: 10.1128/iai.56.1.230-233.1988.
We examined whether infection with enterotoxigenic Escherichia coli (ETEC) producing the heat-labile enterotoxin (LT) can prime the gut immune system to respond more efficiently to the immunologically related cholera B subunit component of a recently developed oral B subunit-whole-cell cholera vaccine (B-WCV). Nine Bangladeshi adults who had been hospitalized for watery diarrhea caused by LT-producing ETEC were given a single oral immunization with B-WCV on day 28 after hospital admission. The vaccine preparation used was adjusted to contain a lower-than-usual dose of B subunit, which had been found in previous studies to elicit a significant gut mucosal immunoglobulin A antitoxin response mainly in individuals with previous toxin-specific priming of their gut immune system. For comparison, nine patients convalescing from severe cholera disease and eight healthy subjects with no recent history of either cholera or ETEC infection were given the same oral vaccination with B-WCV. Vaccination in the ETEC convalescents induced an immunoglobulin A antitoxin response in intestinal lavage fluid which was comparable with that in the vaccinated cholera convalescents and superior to that in the vaccinated, previously uninfected controls. By contrast, only the cholera patients responded with anamnestic-type anti-cholera lipopolysaccharide antibody titer rises in the intestine after vaccination. These data support the specificity of the anamnestic anti-cholera toxin response in the ETEC patients after vaccination with cholera B-WCV.
我们研究了感染产热不稳定肠毒素(LT)的产肠毒素大肠杆菌(ETEC)是否能使肠道免疫系统更有效地对最近开发的口服B亚单位-全细胞霍乱疫苗(B-WCV)中与免疫相关的霍乱B亚单位成分作出反应。9名因产LT的ETEC引起的水样腹泻而住院的孟加拉国成年人在入院后第28天接受了一次口服B-WCV免疫。所用疫苗制剂经调整,含有低于常规剂量的B亚单位,此前研究发现,该剂量主要在肠道免疫系统先前经毒素特异性启动的个体中引发显著的肠道粘膜免疫球蛋白A抗毒素反应。作为对照,9名正在从严重霍乱疾病中康复的患者和8名近期无霍乱或ETEC感染史的健康受试者接受了相同的口服B-WCV疫苗接种。ETEC康复者接种疫苗后,肠道灌洗液中诱导出的免疫球蛋白A抗毒素反应与接种疫苗的霍乱康复者相当,且优于接种疫苗的未感染对照组。相比之下,只有霍乱患者在接种疫苗后肠道中出现回忆型抗霍乱脂多糖抗体滴度升高。这些数据支持了ETEC患者接种霍乱B-WCV疫苗后回忆型抗霍乱毒素反应的特异性。